Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

416691

	registered interest
	date	04/09/2015
	answering body	Department for Work and Pensions
	answering dept id	29
	answering dept short name	Work and Pensions
	answering dept sort name	Work and Pensions
	hansard heading	Employment and Support Allowance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Work and Pensions, how many employment and support allowance claimants with (a) Parkinson's disease, (b) rheumatoid arthritis, (c) motor neurone disease, (d) multiple sclerosis and (e) cystic fibrosis have been (i) placed in the support group, (ii) placed in the work-related activity group and (iii) found fit for work since 2008; and if he will make a statement.
	tabling member constituency	Torfaen
	tabling member printed	Nick Thomas-Symonds
	uin	8972
	answer	answer is ministerial correction date of answer 09/09/2015 answer text <p /> <p>Outcomes of initial and repeat Employment and Support Allowance (ESA) functional assessments and Incapacity Benefits Reassessments (IBR) by disease code: October 2008 – September 2014</p><p> </p><table><tbody><tr><td><p> </p></td><td><p> </p></td><td><p>Cystic Fibrosis</p></td><td><p>Spinal Muscular Atrophy</p></td><td><p>Parkinson’s Disease</p></td><td><p>Multiple Sclerosis</p></td><td><p>Other Rheumatoid Arthritis</p></td></tr><tr><td rowspan="3"><p>Initial claim</p></td><td><p>SG</p></td><td><p>800</p></td><td><p>1,100</p></td><td><p>1,500</p></td><td><p>6,900</p></td><td><p>3,000</p></td></tr><tr><td><p>WRAG</p></td><td><p>100</p></td><td><p>100</p></td><td><p>700</p></td><td><p>2,600</p></td><td><p>3,400</p></td></tr><tr><td><p>FFW</p></td><td><p>100</p></td><td><p>-</p></td><td><p>500</p></td><td><p>1,700</p></td><td><p>3,800</p></td></tr><tr><td rowspan="3"><p>Repeat claim</p></td><td><p>SG</p></td><td><p>500</p></td><td><p>200</p></td><td><p>1,100</p></td><td><p>7,000</p></td><td><p>4,300</p></td></tr><tr><td><p>WRAG</p></td><td><p>100</p></td><td><p>-</p></td><td><p>500</p></td><td><p>2,200</p></td><td><p>3,900</p></td></tr><tr><td><p>FFW</p></td><td><p>-</p></td><td><p>-</p></td><td><p>100</p></td><td><p>300</p></td><td><p>1,100</p></td></tr><tr><td rowspan="3"><p>IBR claim</p></td><td><p>SG</p></td><td><p>600</p></td><td><p>200</p></td><td><p>1,200</p></td><td><p>15,000</p></td><td><p>5,800</p></td></tr><tr><td><p>WRAG</p></td><td><p>100</p></td><td><p>-</p></td><td><p>300</p></td><td><p>2,600</p></td><td><p>5,000</p></td></tr><tr><td><p>FFW</p></td><td><p>-</p></td><td><p>-</p></td><td><p>-</p></td><td><p>300</p></td><td><p>1,100</p></td></tr></tbody></table><p> </p><p> </p><p>Source: Data in the tables above is derived from administrative data held by the DWP and assessment data provided by Atos Healthcare.</p><p> </p><p>Notes:</p><p>1. Figures are rounded to the nearest 100. “-“denotes nil or under 50.</p><p>2. SG – Support Group</p><p>WRAG – Work Related Activity Group</p><p>FFW – Fit For Work</p><p>3. The outcome recorded is the final DWP Decision Maker’s decision or the recommendation made by the Atos Healthcare Professional where the Decision Maker’s decision is not yet available.</p><p>4. Motor neurone disease is shown in the table as 'Spinal muscular atrophy'.</p><p>5. The data presented above comes from benefit claims data held by the Department for Work and Pensions. In October 2008, ESA replaced IB for new claims. Starting with a trial in October 2010, and reaching a full scale national roll-out in April 2011, existing IB claims began to be phased out, with claimants reassessed to see if they qualify for ESA instead.</p><p>6. The reassessment of existing incapacity benefits claimants was rolled out nationally from April 2011.</p> answering member constituency Witham answering member printed Priti Patel question first answered 09/09/2015 14:19:09 answering member 4066 label Biography information for Priti Patel
	tabling member	4479 label Biography information for Nick Thomas-Symonds

429161

	registered interest
	date	18/11/2015
	answering body	Department for Work and Pensions
	answering dept id	29
	answering dept short name	Work and Pensions
	answering dept sort name	Work and Pensions
	hansard heading	State Retirement Pensions: Females
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Work and Pensions, with reference to his oral contribution of 20 June 2011, Official Report, column 52, on state pensions for women, what meetings he has had on the transitional arrangements referred to (a) between 20 June 2011 and 7 May 2015 and (b) since 8 May 2015.
	tabling member constituency	Torfaen
	tabling member printed	Nick Thomas-Symonds
	uin	16900
	answer	answer is ministerial correction date of answer 23/11/2015 answer text <p>Ministers discussed and considered transitional arrangements during the passage on the Pensions Bill 2011.</p><p>The Government carried out extensive analysis of the impacts of bringing forward the rise to age 66 when legislating for the change in State Pension age. A final Impact Assessment was published in November 2011 following Royal Assent the Pensions Act 2011.</p><p><a href="https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/181461/pensions-bill-2011-summary-of-impacts.pdf" target="_blank">https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/181461/pensions-bill-2011-summary-of-impacts.pdf</a></p><p>The Impact Assessment includes analysis of the decision to amend the timetable originally set out in the bill so as to cap the maximum increase at 18 months rather than 2 years. This concession benefited almost a quarter of a million women, who would otherwise have experienced delays of up to two years. A similar number of men also benefited from a reduced increase, and the concession was worth around £1 billion in total.</p><p>The Government will not be revisiting the State Pension age arrangements for women affected by the 2011 Act.</p><br /> answering member constituency North Swindon answering member printed Justin Tomlinson grouped question UIN 16901 question first answered 23/11/2015 15:51:17 answering member 4105 label Biography information for Justin Tomlinson
	tabling member	4479 label Biography information for Nick Thomas-Symonds

429162

	registered interest
	date	18/11/2015
	answering body	Department for Work and Pensions
	answering dept id	29
	answering dept short name	Work and Pensions
	answering dept sort name	Work and Pensions
	hansard heading	State Retirement Pensions: Females
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Work and Pensions, with reference to his oral contribution of 20 June 2011, Official Report, column 52, on state pensions for women, whether he plans to make an announcement of transitional provisions prior to the introduction of the single-tier state pension.
	tabling member constituency	Torfaen
	tabling member printed	Nick Thomas-Symonds
	uin	16901
	answer	answer is ministerial correction date of answer 23/11/2015 answer text <p>Ministers discussed and considered transitional arrangements during the passage on the Pensions Bill 2011.</p><p>The Government carried out extensive analysis of the impacts of bringing forward the rise to age 66 when legislating for the change in State Pension age. A final Impact Assessment was published in November 2011 following Royal Assent the Pensions Act 2011.</p><p><a href="https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/181461/pensions-bill-2011-summary-of-impacts.pdf" target="_blank">https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/181461/pensions-bill-2011-summary-of-impacts.pdf</a></p><p>The Impact Assessment includes analysis of the decision to amend the timetable originally set out in the bill so as to cap the maximum increase at 18 months rather than 2 years. This concession benefited almost a quarter of a million women, who would otherwise have experienced delays of up to two years. A similar number of men also benefited from a reduced increase, and the concession was worth around £1 billion in total.</p><p>The Government will not be revisiting the State Pension age arrangements for women affected by the 2011 Act.</p><br /> answering member constituency North Swindon answering member printed Justin Tomlinson grouped question UIN 16900 question first answered 23/11/2015 15:51:17 answering member 4105 label Biography information for Justin Tomlinson
	tabling member	4479 label Biography information for Nick Thomas-Symonds

416690

	registered interest
	date	04/09/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Drugs: Licensing
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps his Department has taken to act upon the outcomes of the stakeholder roundtable discussion it convened on 11 February 2015 on access to off-patent drugs.
	tabling member constituency	Torfaen
	tabling member printed	Nick Thomas-Symonds
	uin	8971
	answer	answer is ministerial correction date of answer 09/09/2015 answer text <p>The Department convened a roundtable event on 11 February 2015 to discuss what action, could most expeditiously be taken to ensure that robust evidence about new uses for existing drugs is produced, disseminated and then used to inform clinical decision making about these medicines.</p><p> </p><p> </p><p> </p><p>A number of areas were identified where further work could help improve matters, including:</p><p> </p><p> </p><p> </p><p>- supporting clinicians to identify the latest robust evidence on patient care and take it up in their own practice; and</p><p> </p><p>- supporting and mapping clear pathways for innovators and those who want to &quot;re-purpose&quot; drugs.</p><p> </p><p> </p><p> </p><p>Officials have since been engaging with stakeholders to progress outputs associated with this event.</p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 8970 8974 question first answered 09/09/2015 16:26:29 answering member 4020 label Biography information for George Freeman
	tabling member	4479 label Biography information for Nick Thomas-Symonds

416692

	registered interest
	date	04/09/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Drugs: Licensing
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with which organisations and individuals (a) Ministers and (b) officials in his Department have discussed the availability of repurposed off-patent drugs on the NHS since 12 February 2014.
	tabling member constituency	Torfaen
	tabling member printed	Nick Thomas-Symonds
	uin	8973
	answer	answer is ministerial correction date of answer 09/09/2015 answer text <p>Following the 11 February 2015 Roundtable Event on <em>‘Translating Evidence in to Clinical Practice’</em>, officials are continuing to work with key stakeholders including charities, health professional networks, the General Medical Council, the National Institute for Health and Care Excellence and the Medicines &amp; Healthcare products Regulatory Agency. Officials have since been engaging with stakeholders to progress outputs associated with this event.</p><p> </p><p> </p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 09/09/2015 16:00:15 answering member 4020 label Biography information for George Freeman
	tabling member	4479 label Biography information for Nick Thomas-Symonds

416693

	registered interest
	date	04/09/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Drugs: Licensing
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what progress has been made in implementing non-legislative measures to provide routine access on the NHS to off-patent drugs that have been proven to be clinically effective for new indications.
	tabling member constituency	Torfaen
	tabling member printed	Nick Thomas-Symonds
	uin	8974
	answer	answer is ministerial correction date of answer 09/09/2015 answer text <p>The Department convened a roundtable event on 11 February 2015 to discuss what action, could most expeditiously be taken to ensure that robust evidence about new uses for existing drugs is produced, disseminated and then used to inform clinical decision making about these medicines.</p><p> </p><p> </p><p> </p><p>A number of areas were identified where further work could help improve matters, including:</p><p> </p><p> </p><p> </p><p>- supporting clinicians to identify the latest robust evidence on patient care and take it up in their own practice; and</p><p> </p><p>- supporting and mapping clear pathways for innovators and those who want to &quot;re-purpose&quot; drugs.</p><p> </p><p> </p><p> </p><p>Officials have since been engaging with stakeholders to progress outputs associated with this event.</p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 8970 8971 question first answered 09/09/2015 16:26:29 answering member 4020 label Biography information for George Freeman
	tabling member	4479 label Biography information for Nick Thomas-Symonds

416694

	registered interest
	date	04/09/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Drugs: Licensing
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what the outcome was of the stakeholder roundtable discussion on off-patent drugs convened by his Department on 11 February 2015.
	tabling member constituency	Torfaen
	tabling member printed	Nick Thomas-Symonds
	uin	8970
	answer	answer is ministerial correction date of answer 09/09/2015 answer text <p>The Department convened a roundtable event on 11 February 2015 to discuss what action, could most expeditiously be taken to ensure that robust evidence about new uses for existing drugs is produced, disseminated and then used to inform clinical decision making about these medicines.</p><p> </p><p> </p><p> </p><p>A number of areas were identified where further work could help improve matters, including:</p><p> </p><p> </p><p> </p><p>- supporting clinicians to identify the latest robust evidence on patient care and take it up in their own practice; and</p><p> </p><p>- supporting and mapping clear pathways for innovators and those who want to &quot;re-purpose&quot; drugs.</p><p> </p><p> </p><p> </p><p>Officials have since been engaging with stakeholders to progress outputs associated with this event.</p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 8971 8974 question first answered 09/09/2015 16:26:29 answering member 4020 label Biography information for George Freeman
	tabling member	4479 label Biography information for Nick Thomas-Symonds

416695

	registered interest
	date	04/09/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Chronic Obstructive Pulmonary Disease
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps he is taking to raise awareness of support groups to people with chronic obstructive pulmonary disease.
	tabling member constituency	Torfaen
	tabling member printed	Nick Thomas-Symonds
	uin	8894
	answer	answer is ministerial correction date of answer 14/09/2015 answer text <p>Raising awareness of support groups to people with chronic obstructive pulmonary disease is not a part of our public awareness campaign on breathlessness, however, we do signpost to the British Lung Foundation and the British Heart Foundation on our website.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 14/09/2015 15:08:52 answering member 3918 label Biography information for Jane Ellison
	tabling member	4479 label Biography information for Nick Thomas-Symonds

416696

	registered interest
	date	04/09/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Chronic Obstructive Pulmonary Disease
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps his Department is taking to raise public awareness of chronic obstructive pulmonary disease.
	tabling member constituency	Torfaen
	tabling member printed	Nick Thomas-Symonds
	uin	8895
	answer	answer is ministerial correction date of answer 14/09/2015 answer text <p>Public Health England has developed a campaign to raise awareness of the symptom of breathlessness which ran as a local pilot in Oldham and Rochdale from 24 February – 23 March 2014 and as a regional pilot in the East of England 2 February – 1 March 2015.</p><p> </p><p> </p><p> </p><p>The Breathlessness campaign aims to encourage those with inappropriate breathlessness (breathlessness that is disproportionate to the level of activity undertaken i.e. at rest or on minimal exertion) to go and see their general practitioner (GP). It is primarily aimed at earlier diagnosis of heart and lung disease, including chronic obstructive pulmonary disease, with scope to reduce premature mortality and to improve the quality of life of those living with these conditions. The key message of the campaign is “If you get out of breath doing things that you used to be able to do, see your GP. Getting out of breath could be a sign of heart or lung disease. Finding it early makes it more treatable, so don’t ignore it, tell your doctor”.</p><p> </p><p> </p><p> </p><p>Evaluation of the regional pilot is still underway, although early findings from follow-up in-depth interviews with a sample of local GPs and pharmacists and pre and post awareness tracking research among the public, are positive.</p><p> </p><p> </p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 14/09/2015 16:18:06 answering member 3918 label Biography information for Jane Ellison
	tabling member	4479 label Biography information for Nick Thomas-Symonds

428798

	registered interest
	date	17/11/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, pursuant to the Answer given by the Parliamentary Under-Secretary of State for Care Quality during Oral Questions on 17 November 2015 on the establishment of a working party to examine issues regarding the availability of off-patent, repurposed drugs, when the working party was established; what the working party's scope and terms of reference are; which organisations and individuals have been invited to join the working party; and when the next meeting of the working party will be convened.
	tabling member constituency	Torfaen
	tabling member printed	Nick Thomas-Symonds
	uin	16729
	answer	answer is ministerial correction date of answer 20/11/2015 answer text <p>The Government has not established a working party in relation to the Off-Patent Drugs Bill. We did hold a roundtable event in February 2015 with key stakeholders including charities and agreed several follow up actions. We have now agreed additional further actions:</p><p>- arrange a further roundtable event specifically for those charities who would like to explore the Bill in more detail;</p><p>- input in to the work of the Off-Patent Drugs Bill All Party Parliamentary Group; and</p><p>- hold a Ministerial drop-in session on 30 November, for those who would like to discuss the Bill further. This will be hosted by myself.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 20/11/2015 14:51:05 answering member 4020 label Biography information for George Freeman
	tabling member	4479 label Biography information for Nick Thomas-Symonds